SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
52157 680 3 CRSP
Emcee:  Biomaven Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
50603That is interesting. But maybe not all bad - it turns out the existing media serBiomaven-1/4/2019
50602Interesting article. Scientists Have Been Studying Cancers in a Very Strange Wrkrw51/2/2019
50601OT - on the course of MS in my wife Karen Summary: Karen had MS at 19, many yeIRWIN JAMES FRANKEL271/1/2019
50600Forgive me for jumping in here, but it's a question that has been rolling arquidditch-12/31/2018
50599I think this is all a confusion. Hematocrit is *very* highly correlated with Hb,Biomaven212/31/2018
50598OK, so it appears the bear case is like this: There's apparently evidence ttuck-12/31/2018
50597Happy and Prosperous New Year to ALL!Miljenko Zuanic112/31/2018
50596I hadn't seen that ibuprofen article - very interesting, and seems well doneBiomaven312/31/2018
50595this surprised me would love to hear your thoughts ncbi.nlm.nih.govchris714-12/31/2018
50594The “2019 Biotech Stock Charity Contest” SI board is now up and ready to accept BulbaMan-12/25/2018
50593Thanks Peter, was afraid of that.fred hayes-12/24/2018
50592>>NVLN The debt holders seem to have all the cards here. Hard to see theBiomaven-12/24/2018
50591Just to be extra clear -- My last post was not to recommend nvln. Just looking fred hayes-12/24/2018
50590Jim, I keep coming back to NVLN. 19 million shares around 90-some cents, say mfred hayes-12/24/2018
50589GILD, IONS, ANIK ArtArt Bechhoefer-12/24/2018
50588Citi Analyst: success rate 38%, annual return 2.1% tipranks.comJulius Wong112/24/2018
50587With tax-loss selling on the wane and over for normal clearing on 12/27, we coulIRWIN JAMES FRANKEL-12/24/2018
50586Calling All Biotechies!!! The “2019 Biotech Stock Charity Contest” is now acceptBulbaMan-12/23/2018
50585Post hoc BS.DewDiligence_on_SI-12/23/2018
50584Anyone with idea what is going on with XBIT? ....to be more specific: finance.yMiljenko Zuanic-12/23/2018
50583Yeah, believe I'll space it out even further. Thanks!scaram(o)uche-12/23/2018
50582The “nocebo effect": Another factor to consider when evaluating the cost/beBulbaMan-12/22/2018
50581I've been taking the LEF brand of super K (I think) and remember reading lonatticus4paws-12/22/2018
50580>> There seems to be some tendency to think mk-4 is less effective becausescaram(o)uche-12/22/2018
50579Dem "analysts" ain't that dumb. Because fgen in the past hasn'linhtu-12/21/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News